Skip to main content
SpringerLink
Log in

Colorectal Carcinoma

  • Chapter
Practical FDG Imaging: A Teaching File

  • 132 Accesses

Abstract

Colorectal carcinoma is the third most common noncutaneous malignancy in the United States, representing 13% of all malignancies. There are over 133,000 new cases detected annually with almost 55,000 annual deaths.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gupta NC, Falk PM, Frank AL, Thorson AM, Frick MP, Bowman B: Preoperative staging of colorectal carcinoma using positron emission tomography. Nebr Med J 1993;78(2):30–35.

    PubMed  CAS  Google Scholar 

  2. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al.: Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998;206(3):755–760.

    PubMed  CAS  Google Scholar 

  3. Steele G Jr, Bleday R, Mayer R, Lindblad A, Petrelli N, Weaver D: A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group protocol 6584. J Clin Oncol 1991; 9:1105–1112.

    PubMed  Google Scholar 

  4. Yonekura Y, Benua RS, Brill AB, et al.: Increased accumulation of 2-deoxy-2[18F]fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 1982;23:1133–1137.

    PubMed  CAS  Google Scholar 

  5. Strauss LG, Clorius JH, Schlag P, et al.: Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329–332.

    PubMed  CAS  Google Scholar 

  6. Ito K, Kato T, Tadokoro M, et al.: Recurrent rectal cancer and scar: Differentiation with PET and MR imaging. Radiology 1992;182:549–552.

    PubMed  CAS  Google Scholar 

  7. Gupta NC, Falk PM, Frank AL, Thorson AM, Firck MP, Bowman B: Preoperative staging of colorectal carcinoma using positron emission tomography. Nebr Med J 1993;78:30–35.

    PubMed  CAS  Google Scholar 

  8. Falk PM, Gupta NC, Thorson AG, et al.: Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994; 37:153–156.

    Article  PubMed  CAS  Google Scholar 

  9. Schiepers C, Penninckx F, De Vadder N, et al.: Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging. Eur J Surg Oncol 1995;21: 517–522.

    Article  PubMed  CAS  Google Scholar 

  10. Vitola JV, Delbeke D, Sandler MP, et al.: Positron emission tomography to stage metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21–26.

    Article  PubMed  CAS  Google Scholar 

  11. Delbeke D, Vitola J, Sandler MP, et al.: Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196–1201.

    PubMed  CAS  Google Scholar 

  12. Valk PE, Abella-Columna E, Haseman MK, et al.: Whole-body PET imaging with F-18-fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134:503–511.

    Article  PubMed  CAS  Google Scholar 

  13. Ruhlmann J, Schomburg A, Bender H, et al.: Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice. Dis Colon Rectum 1997;40:1195–1204.

    Article  PubMed  CAS  Google Scholar 

  14. Flamen P, Stroobants S, Van Cutsem E, et al.: Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol 1999;17(3):894–901.

    PubMed  CAS  Google Scholar 

  15. Akhurst T, Larson SM: Positron emission tomography imaging of colorectal cancer. Semin Oncol 1999;26(5):577–583.

    PubMed  CAS  Google Scholar 

  16. Kim EE, Chung SK, Haynie TP, et al.: Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 1992;12:269–279.

    PubMed  CAS  Google Scholar 

  17. Vogel SB, Drane WE, Ros PR, Kerns SR, Bland KI: Prediction of surgical resectability in patients with hepatic colorectal metastases. Ann Surg 1994;219:508–516.

    Article  PubMed  CAS  Google Scholar 

  18. Imbriaco M, Akhurst T, Hilton S, et al.: Whole-body FDG-PET in patients with recurrent colorectal carcinoma. A comparative study with CT. Clin Positron Imaging 2000;3(3):107–114.

    Article  PubMed  Google Scholar 

  19. Imdahl A, Reinhardt MJ, Nitzsche EU, et al.: Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. Arch Surg 2000;385(2):129–134.

    Article  CAS  Google Scholar 

  20. Staib L, Schirrmeister H, Reske SN, Beger HG: Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000;180(1):1–5.

    Article  PubMed  CAS  Google Scholar 

  21. Lai DT, Fulham M, Stephen MS, et al.: The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer. Arch Surg 1996;131:703–707.

    PubMed  CAS  Google Scholar 

  22. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al.: Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography. Ann Surg Oncol 1997;4:613–620.

    Article  PubMed  CAS  Google Scholar 

  23. Beets G, Penninckx F, Schiepers C, et al.: Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 1994;81:1666–1670.

    Article  PubMed  CAS  Google Scholar 

  24. Huebner RH, Park KC, Shepherd JE, et al.: A meta-analysis of the literature for whole-body FDG PET detection of colorectal cancer. J Nucl Med 2000;41:1177–1189.

    PubMed  CAS  Google Scholar 

  25. Flanagan FL, Dehdashti F, Ogunbiyi OA, Siegel BA: Utility of FDG PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Annals of Surgery 1998;227(3): 319–323.

    Article  PubMed  CAS  Google Scholar 

  26. Gambhir SS, Valk P, Shepherd J, Hoh C, Allen M, Phelps ME: Cost effective analysis modeling of the role of FDG PET in the management of patients with recurrent colorectal cancer. J Nucl Med 1997;38:90P.

    Google Scholar 

  27. Whiteford MH, Whiteford HM, Yee LF, et al.: Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000;43(6):759–767; discussion 767-770.

    Article  PubMed  CAS  Google Scholar 

  28. Berger KL, Nicholson SA, Dehadashti F, Siegel BA: FDG PET evaluation of mucinous neoplasms: Correlation of FDG uptake with histopathologic features. Am J Roentgenol 2000; 174(4):1005–1008.

    CAS  Google Scholar 

  29. Findlay M, Young H, Cunningham D, et al.: Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil. J Clin Oncol 1996;14:700–708.

    PubMed  CAS  Google Scholar 

  30. Vitola JV, Delbeke D, Meranze SG, Mazer MJ, Pinson CW: Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer 1996;78: 2216–2222.

    Article  PubMed  CAS  Google Scholar 

  31. Guillem J, Calle J, Akhurst T, et al.: Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 2000;43:18–24

    Article  PubMed  CAS  Google Scholar 

References

  1. Gupta NC, Falk PM, Frank AL, Thorson AM, Frick MP, Bowman B: Preoperative staging of colorectal carcinoma using positron emission tomography. Nebr Med J 1993;78(2):30–35.

    PubMed  CAS  Google Scholar 

References

  1. Strauss LG, Clorius JH, Schlag P, et al.: Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329–332.

    PubMed  CAS  Google Scholar 

  2. Ito K, Kato T, Tadokoro M, et al.: Recurrent rectal cancer and scar: Differentiation with PET and MR imaging. Radiology 1992;182:549–552.

    PubMed  CAS  Google Scholar 

  3. Falk PM, Gupta NC, Thorson AG, et al.: Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994; 37:153–156.

    Article  PubMed  CAS  Google Scholar 

  4. Schiepers C, Penninckx F, De Vadder N, et al.: Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging. Eur J Surg Oncol 1995;21:517–522.

    Article  PubMed  CAS  Google Scholar 

  5. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al.: Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography. Annals of Surgical Oncology 1997;4:613–620.

    Article  PubMed  CAS  Google Scholar 

  6. Beets G, Penninckx F, Schiepers C, et al.: Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 1994;81:1666–1670.

    Article  PubMed  CAS  Google Scholar 

References

  1. Huebner RH, Park KC, Shepherd JE, et al.: A meta-analysis of the literature for whole-body FDG PET detection of colorectal cancer. J Nucl Med 2000;41:1177–1189.

    PubMed  CAS  Google Scholar 

  2. Whiteford MH, Whiteford HM, Yee-LF, et al.: Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000;43:759–770.

    Article  PubMed  CAS  Google Scholar 

  3. Berger KL, Nicholson SA, Dehadashti F, Siegel BA: FDG PET evaluation of mucinous neoplasms: Correlation of FDG uptake with histopathologic features. Am J Roentgenol 2000; 174(4):1005–1008.

    CAS  Google Scholar 

References

  1. Flanagan FL, Dehdashti F, Ogunbiyi OA, Siegel BA: Utility of FDG PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Annals of Surgery 1998;227(3): 319–323.

    Article  PubMed  CAS  Google Scholar 

  2. Valk PE, Abella-Columna E, Haseman MK, et al.: Whole-body PET imaging with F-18-fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134:503–511.

    Article  PubMed  CAS  Google Scholar 

References

  1. Schiepers C, Penninckx F, De Vadder N, et al.: Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging. Eur J Surg Oncol 1995;21:517–522.

    Article  PubMed  CAS  Google Scholar 

  2. Vitola JV, Delbeke D, Sandler MP, et al.: Positron emission tomography to stage metastatic colorectal carcinoma to the liver. Am J Surg 1996; 171:21–26.

    Article  PubMed  CAS  Google Scholar 

  3. Delbeke D, Vitola JV, Sandler MP, et al.: Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196–1201.

    PubMed  CAS  Google Scholar 

  4. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al.: Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography. Annals of Surgical Oncology 1997;4:613–620.

    Article  PubMed  CAS  Google Scholar 

  5. Valk PE, Abella-Columna E, Haseman MK, et al.: Whole-body PET imaging with F-18-fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134:503–511.

    Article  PubMed  CAS  Google Scholar 

  6. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF: Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Research 2000;20:2189–2192.

    PubMed  CAS  Google Scholar 

  7. Cook GJR, Fogelman I: The role of positron emission tomography in the management of bone metastases. Cancer 2000;88(S12):2927–2933.

    Article  PubMed  CAS  Google Scholar 

  8. Franzius C, Sciuk J, Daldrup-Link HE, et al.: FDG-PET for detection of osseous metastases from malignant primary bone tumors: Comparison with bone scintigraphy. Eur J Nucl Med 2000;27:1305–1311.

    Article  PubMed  CAS  Google Scholar 

  9. Moog F, Kotzerke J, Reske SN: FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 1999;40:1407–1413.

    PubMed  CAS  Google Scholar 

  10. Yeh SD, Imbriaco M, Larson SM, et al.: Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nucl Med Biol 1996;23:693–697.

    Article  PubMed  CAS  Google Scholar 

  11. Shreve PD, Grossman HB, Gross MD, Wahl RL: Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-(F-18)fluoro-D-Glucose. Radiology 1996;199:751–756.

    PubMed  CAS  Google Scholar 

  12. Bury T, Barreto A, Daenen F, et al.: Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998;25:1244–1247.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Dominique Delbeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tsuyoshi Komori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William H. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, 37232, USA

    Dominique Delbeke MD, PhD , William H. Martin MD , James A. Patton PhD  & Martin P. Sandler MD , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Delbeke, D., Komori, T., Martin, W.H. (2002). Colorectal Carcinoma. In: Delbeke, D., Martin, W.H., Patton, J.A., Sandler, M.P. (eds) Practical FDG Imaging: A Teaching File. Springer, New York, NY. https://doi.org/10.1007/978-0-387-22453-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-22453-4_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95292-5

  • Online ISBN: 978-0-387-22453-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation